VT
FMED icon

Vise Technologies’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Vise Technologies’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$234K Hold
8,648
– – ﹤0.01% 1298
2025
Q4 		$234K Buy
+8,648
New +$233K ﹤0.01% 1308

Other funds holding FMED

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BW
BXM Wealth Englewood, Colorado $130M AUM 29.16% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vise Technologies's FMED Position: Q1 2026 in Review

Vise Technologies held its Fidelity Disruptive Medicine ETF (FMED) position steady in Q1 2026 at 8,648 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #1298.

Vise Technologies first reported a position in FMED in Q4 2025 and has held it in 2 quarters since. 11 funds tracked by Wall St. Rank hold FMED as of Q1 2026.

  • Vise Technologies held 8,648 shares of Fidelity Disruptive Medicine ETF worth $234K as of Q1 2026.
  • Vise Technologies left its Fidelity Disruptive Medicine ETF share count unchanged in Q1 2026.
  • Fidelity Disruptive Medicine ETF made up ﹤0.01% of Vise Technologies's portfolio in Q1 2026, its #1298 holding.
  • Vise Technologies first reported a position in Fidelity Disruptive Medicine ETF in Q4 2025 and has held it in 2 quarters since.
  • 11 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.